EC Number |
Inhibitors |
Structure |
---|
1.14.14.141 | (+)-columbianetin |
i.e. (+)-3,4,2',3'-D4-columbianetin, competitive inhibition, binds to the active site, analogy modeling and docking analysis, mechanism-based inactivation |
|
1.14.14.141 | Ancymidole |
48% inhibition of the psoralen synthase at 0.05 mM, 29% at 0.005 mM |
|
1.14.14.141 | Ancymidole |
13% inhibition of the psoralen synthase at 0.05 mM |
|
1.14.14.141 | BAS 110 |
34% inhibition of the psoralen synthase at 0.001 mM, 30% at 0.0002 mM |
|
1.14.14.141 | BAS 110 |
72% inhibition of the psoralen synthase at 0.05 mM, 38% at 0.005 mM |
|
1.14.14.141 | BAS 111 |
52% inhibition of the psoralen synthase at 0.001 mM, 33% at 0.0002 mM |
|
1.14.14.141 | BAS 111 |
complete inhibition of the psoralen synthase at 0.001 mM, 86% at 0.0002 mM |
|
1.14.14.141 | BAS 978 |
10% inhibition of the psoralen synthase at 0.001 mM |
|
1.14.14.141 | BAS 978 |
complete inhibition of the psoralen synthase at 0.05 mM, 68% at 0.005 mM |
|
1.14.14.141 | carbon monoxide |
- |
|